You have 9 free searches left this month | for more free features.

Ranibizumab

Showing 1 - 25 of 714

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Branch Retinal Vein Occlusion, Ranibizumab, Laser Photocoagulation Trial in Beijing (Ranibizumab combined macular laser,

Completed
  • Branch Retinal Vein Occlusion
  • +2 more
  • Ranibizumab combined macular laser
  • Ranibizumab
  • Beijing, Beijing, China
    Beijing Hospital
Dec 25, 2022

Retina Disease, Retinopathy of Prematurity, Ranibizumab Trial in Zagazig (Ranibizumab (0.25 mg/0.025 mL))

Completed
  • Retina Disease
  • +2 more
  • Ranibizumab (0.25 mg/0.025 mL)
  • Zagazig, Egypt
    Zagazig University, Faculty of medicine
Jan 26, 2023

Neovascular Age Related Macular Degeneration, nAMD Trial in Wenzhou City (PDS with ranibizumab (100 mg/mL), Ranibizumab (10

Not yet recruiting
  • Neovascular Age Related Macular Degeneration
  • nAMD
  • PDS with ranibizumab (100 mg/mL)
  • Ranibizumab (10 mg/mL)
  • Wenzhou City, China
    Eye Hospital, Wenzhou Medical University
Feb 2, 2023

Focal Laser Single Intravitreal Ranibizumab Retinal Artery

Completed
  • Retinal Artery Macroaneurysm
  • Dual focal laser and intravitreal Ranibizumab injection
  • Cairo, Egypt
    Kasr alainy faculty of medicine
Jan 29, 2023

Diabetic Macular Edema Trial in Cairo (intra-vitreal injection of Ranibizumab, anterior chamber paracentesis)

Recruiting
  • Diabetic Macular Edema
  • intra-vitreal injection of Ranibizumab
  • anterior chamber paracentesis
  • Cairo, Egypt
    Ain shams university
May 15, 2023

Ranibizumab 0.5 mg for Diabetic Macular Edema With Initial

Completed
  • Diabetic Macular Edema
    • Seoul, Korea, Republic of
      Novartis Investigative Site
    Apr 4, 2023

    Diabetic Retinopathy, Postoperative Recurrent Vitreous Hemorrhage, Pars Plana Vitrectomy Trial in Tianjin (Ranibizumab

    Recruiting
    • Diabetic Retinopathy
    • +3 more
    • Ranibizumab Injection
    • PPV
    • Tianjin, Tianjin, China
      Tianjin medical university eye hosipital
    Aug 11, 2022

    Effectiveness and Safety of Lucentis® 0.2mg in Retinopathy of

    Recruiting
    • Retinopathy of Prematurity
    • Ranibizumab
    • Chengdu, Sichuan, China
    • +2 more
    Jan 25, 2023

    Neovascular Age-related Macular Degeneration Trial in United States (SUSVIMO (ranibizumab injection), LUCENTIS (ranibizumab

    Recruiting
    • Neovascular Age-related Macular Degeneration
    • SUSVIMO (ranibizumab injection)
    • LUCENTIS (ranibizumab injection)
    • Mesa, Arizona
    • +32 more
    Jan 13, 2023

    Wet Age-related Macular Degeneration Trial (Ranibizumab, SCT510A)

    Not yet recruiting
    • Wet Age-related Macular Degeneration
    • (no location specified)
    Jul 28, 2022

    Non-Ischemic Central Retinal Vein Occlusion With Macular Edema Trial in Qina (intravitreal injection of Ranibizumab,

    Recruiting
    • Non-Ischemic Central Retinal Vein Occlusion With Macular Edema
    • intravitreal injection of Ranibizumab
    • +3 more
    • Qinā, Qena, Egypt
      Ahmed Ali Ahmed Amer
    Mar 15, 2022

    Neovascular Age-Related Macular Degeneration Trial in Worldwide (Ranibizumab, Aflibercept, Port Delivery System with ranibizumab

    Suspended
    • Neovascular Age-Related Macular Degeneration
    • Ranibizumab
    • +2 more
    • Capital Federal, Argentina
    • +9 more
    Nov 8, 2022

    Mild Non-proliferative Diabetic Retinopathy, Cataract Diabetic, Diabetic Retinopathy Trial in Shanghai (Ranibizumab Injection

    Recruiting
    • Mild Non-proliferative Diabetic Retinopathy
    • +2 more
    • Ranibizumab Injection [Lucentis]
    • Phacoemulsification
    • Shanghai, Shanghai, China
      Department of Ophthalmology, Ruijin Hospital Affiliated Medical,
    May 18, 2022

    Lucentis® in Patients With Retinopathy of Prematurity

    Not yet recruiting
    • Retinopathy of Prematurity
    • Lucentis
    • (no location specified)
    Jun 28, 2022

    Age Related Macular Degeneration Trial in Nedlands (HLX04-O, ranibizumab)

    Recruiting
    • Age Related Macular Degeneration
    • Nedlands, Western Australia, Australia
      Lions Eye Institute
    Feb 7, 2022

    Diabetic Macular Edema Trial in Giza (Lucentis alone group, Lucentis dexamethasone group)

    Completed
    • Diabetic Macular Edema
    • Lucentis alone group
    • Lucentis dexamethasone group
    • Giza, Cairo, Egypt
      Khaled G Abueleinen
    Feb 27, 2022

    Proliferative Diabetic Retinopathy Trial in Beijing (preoperative intravitreal injections of ranibizumab or conbercept)

    Completed
    • Proliferative Diabetic Retinopathy
    • preoperative intravitreal injections of ranibizumab or conbercept
    • Beijing, Beijing, China
      Peking University People's Hospital
    Jun 7, 2022

    naïve Age-related Macular Degeneration Neovascular Type and

    Completed
    • Macular Degeneration
    • Data extraction from medical files
    • Brussels, Belgium
      CHU Brugmann
    Mar 7, 2022

    Diabetic Macular Edema, Macular Ischemia, Diabetic Retinopathy Trial in Cairo (Intravitreal ranibizumab, Intravitreal

    Recruiting
    • Diabetic Macular Edema
    • +3 more
    • Intravitreal ranibizumab
    • Intravitreal bevacizumab
    • Cairo, Egypt
      Cairo University
    Nov 26, 2021

    Central Retinal Vein Occlusion With Macular Edema Trial in Germany (Ranibizumab Injection, Laser photocoagulation)

    Recruiting
    • Central Retinal Vein Occlusion With Macular Edema
    • Ranibizumab Injection
    • Laser photocoagulation
    • Dresden, Germany
    • +13 more
    May 5, 2022

    Diabetic Macular Edema Trial in Ciudad de Mexico (Bevacizumab, Lucentis®)

    Recruiting
    • Diabetic Macular Edema
    • Bevacizumab
    • Lucentis®
    • Bogotá, Colombia
    • +1 more
    Aug 31, 2022

    Retinopathy of Prematurity Both Eyes Trial in Zagazig (Bevacizumab, Ranibizumab)

    Recruiting
    • Retinopathy of Prematurity Both Eyes
    • Bevacizumab, Ranibizumab
    • Zagazig, Egypt
      Zagazig University
    Aug 26, 2021

    Patients Treated With ranibizUmab for REtinal Vein Occlusion

    Terminated
    • Retinal Vein Occlusion
      • Baltimore, Maryland
        Wilmer Eye Institute
      Oct 8, 2021

      Von Hippel-Lindau Syndrome Trial run by the NEI (Ranibizumab, E10030)

      Completed
      • Von Hippel-Lindau Syndrome
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Oct 21, 2021

      Wet Age-related Macular Degeneration Trial in Beijing, Wuhan, Shanghai (CMAB818, Lucentis®)

      Recruiting
      • Wet Age-related Macular Degeneration
      • Beijing, Beijing, China
      • +3 more
      Jun 14, 2022